| Literature DB >> 30463093 |
Georgi Manukjan1, Julia Eilenberger1,2, Oliver Andres3, Christian Schambeck4, Stefan Eber2, Harald Schulze1.
Abstract
Storage pool disease (SPD) covers a group of platelet defects in which α- and/or delta-granules are reduced or cannot be secreted adequately in response to agonists. The detection of delta-granule release defects is hampered by a lack of fast and feasible tests. We aimed to implement a flow cytometry-based kinetic mepacrine assay to better identify and subgroup childhood patients with a mild to moderate bleeding diathesis and compare our method to established laboratory tests. We analysed 50 children with suspected SPD whose initial parameters were re-assessed in a second site visit. Mepacrine uptake and release patterns were correlated with CD63 exposure, platelet ADP/ATP release and content, and the bleeding score ascertained by the ISTH-BAT. Mepacrine release was overall significantly reduced in investigated patients compared with controls. Summarizing, our time-resolved approach proved to be a quick and inexpensive tool that was additionally able to distinguish between mepacrine uptake, mepacrine release, and combined defects. Classification of patients using such a kinetic assay makes it feasible to sensitively detect frequently missed SPD and to group these patients for further analyses and clinical correlations. Georg Thieme Verlag KG Stuttgart · New York.Entities:
Mesh:
Year: 2018 PMID: 30463093 DOI: 10.1055/s-0038-1675574
Source DB: PubMed Journal: Hamostaseologie ISSN: 0720-9355 Impact factor: 1.778